Louis Navellier and the InvestorPlace Research Staff, Author at Daily Trade Alert

This Stock Has Huge Growth Potential As Its Covid-19 Trials Wrap Up

It has an “A” grade in my Portfolio Grader right now, where it carries a strong buy recommendation.

All have taken advantage of their particular markets and through their experience and unique positioning have built strong competitive moats.

If you’re interested in snapping up shares at a significant discount you will have to move quick.

It’s up 78% year-to-date and it gets an “A” rating in my Portfolio Grader.

For a low-beta winner with international exposure, it’s an outstanding pick.